Tauramox (moxidectin) Injectable Solution

Tauramox™ (moxidectin) Injectable Solution is the first generic Cydectin® (moxidectin) Injectable for the treatment of infections and infestations due to internal and external parasites in beef and non-lactating dairy cattle. Producers can expect the same weight gain advantage as with Cydectin® Injectable, but at a lower cost.

• Ready-to-use injectable parasiticide containing 1% moxidectin
• Treats and controls gastrointestinal roundworms, lungworms, cattle grubs, mites and lice
• Proven to effectively protect cattle from reinfection of key internal parasites*
• 21-day pre-slaughter withdrawal
• Injectable formulation offers flexibility when treating external parasites
• Dung beetle friendly
• FDA approved

* Moxidectin Injectable has been proven to effectively protect cattle from reinfection with Dictyocaulus viviparus and Oesophagostomum radiatum for 42 days, Haemonchus placei for 35 days, and Ostertagia ostertagi and Trichostrongylus axei for 14 days.

10 mg moxidectin/mL

Indications

Tauramox™ Injectable, when administered at the recommended dose level of 0.2 mg/2.2 lb (0.2 mg/kg) body weight, is effective in the treatment and control of the following internal and external parasites of cattle

Dosage

The recommended rate of administration for Tauramox™ Injectable is 1 mL for each 110 lb (50 kg) body weight to provide 0.2 mg moxidectin/2.2 lb (0.2 mg/kg) body weight. The table below will assist in the calculation of the appropriate volume of injectable which must be administered based on the weight of animal being treated. Be careful not to overdose animals; estimate animal’s body weight as closely as possible or weigh animals individually.

* Do not underdose. Ensure each animal receives a complete dose based on a current body weight. Underdosing may result in ineffective treatment and encourage the development of parasite resistance.

Administration:

Tauramox ™ Injectable should be administered by subcutaneous injection under the loose skin in front of or behind the shoulder (Figure 1). Needles ½ to ¾ inch in length and 16 to 18 gauge are recommended for subcutaneous injections. Use sterile, dry equipment and aseptic procedures with withdrawing and administering Tauramox™.

Storage:

Store at 59° to 77°F (15° to 25°C). Exposure to temperature up to 104°F (40°C) may be tolerated provided the mean kinetic temperature does not exceed 77°F (25°C). Use within 3 months of first puncture and puncture a maximum of 56 times. If more than 56 punctures are anticipated, the use of multi-dosing equipment is recommended. If using a needle or draw-off spike larger than 16 gauge, discard any remaining product immediately after use.

Safety Data Sheet

Manufacture/Product Label